No paralogue variants have been mapped to residue 1567 for SCN5A.
SCN5A | LICLNMVTMMVETDDQSPEKINILAKINLL>F<VAIFTGECIVKLAALR-HYYFTNSWNIFDF | 1596 |
SCN1A | LICLNMVTMMVETDDQSEYVTTILSRINLV>F<IVLFTGECVLKLISLR-HYYFTIGWNIFDF | 1609 |
SCN2A | LICLNMVTMMVETDDQSQEMTNILYWINLV>F<IVLFTGECVLKLISLR-YYYFTIGWNIFDF | 1599 |
SCN3A | LICLNMVTMMVETDDQGKYMTLVLSRINLV>F<IVLFTGEFVLKLVSLR-HYYFTIGWNIFDF | 1594 |
SCN4A | LICLNMVTMMVETDNQSQLKVDILYNINMI>F<IIIFTGECVLKMLALR-QYYFTVGWNIFDF | 1421 |
SCN7A | LICFQAIAMMIDTDVQSLQMSIALYWINSI>F<VMLYTMECILKLIAFR-CFYFTIAWNIFDF | 1319 |
SCN8A | LICLNMVTMMVETDTQSKQMENILYWINLV>F<VIFFTCECVLKMFALR-HYYFTIGWNIFDF | 1590 |
SCN9A | LICLNMVTMMVEKEGQSQHMTEVLYWINVV>F<IILFTGECVLKLISLR-HYYFTVGWNIFDF | 1572 |
SCN10A | LICLNMITMMVETDDQSEEKTKILGKINQF>F<VAVFTGECVMKMFALR-QYYFTNGWNVFDF | 1544 |
SCN11A | LIILNMISMMAESYNQPKAMKSILDHLNWV>F<VVIFTLECLIKIFALR-QYYFTNGWNLFDC | 1434 |
CACNA1A | MIALNTIVLMMKFYGASVAYENALRVFNIV>F<TSLFSLECVLKVMAFGILNYFRDAWNIFDF | 1635 |
CACNA1B | MIALNTVVLMMKFYDAPYEYELMLKCLNIV>F<TSMFSMECVLKIIAFGVLNYFRDAWNVFDF | 1541 |
CACNA1C | LILLNTICLAMQHYGQSCLFKIAMNILNML>F<TGLFTVEMILKLIAFKPKHYFCDAWNTFDA | 1288 |
CACNA1D | LIMLNTLCLAMQHYEQSKMFNDAMDILNMV>F<TGVFTVEMVLKVIAFKPKGYFSDAWNTFDS | 1294 |
CACNA1E | MIALNTVVLMMKYYSAPCTYELALKYLNIA>F<TMVFSLECVLKVIAFGFLNYFRDTWNIFDF | 1547 |
CACNA1F | LILLNTVALAMQHYEQTAPFNYAMDILNMV>F<TGLFTIEMVLKIIAFKPKHYFTDAWNTFDA | 1259 |
CACNA1G | VIGLNVVTMAMEHYQQPQILDEALKICNYI>F<TVIFVLESVFKLVAFGFRRFFQDRWNQLDL | 1680 |
CACNA1H | IICVNVITMSMEHYNQPKSLDEALKYCNYV>F<TIVFVFEAALKLVAFGFRRFFKDRWNQLDL | 1686 |
CACNA1I | IICLNVVTMSLEHYNQPTSLETALKYCNYM>F<TTVFVLEAVLKLVAFGLRRFFKDRWNQLDL | 1556 |
CACNA1S | LIMLNTICLGMQHYNQSEQMNHISDILNVA>F<TIIFTLEMILKLMAFKARGYFGDPWNVFDF | 1187 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.F1567L | c.4699T>C | Putative Benign | SIFT: Polyphen: |